shutterstock_1277801254_hafakot
hafakot / Shutterstock.com
1 May 2019Big Pharma

Sandoz and EirGenix to market Herceptin biosimilar

A division of  Novartis has entered into an agreement with Taiwan-based  EirGenix to market a medicine which treats some cancer tumours.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
12 March 2019   Switzerland-based Novartis today, March 12, failed to convince the EU General Court that its ‘Smartsurface’ trademark should be registered for contact lenses.

More on this story

Europe
12 March 2019   Switzerland-based Novartis today, March 12, failed to convince the EU General Court that its ‘Smartsurface’ trademark should be registered for contact lenses.

More on this story

Europe
12 March 2019   Switzerland-based Novartis today, March 12, failed to convince the EU General Court that its ‘Smartsurface’ trademark should be registered for contact lenses.